Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.

被引：0
|
作者：
Carmen, SE [1 ]
机构：
[1] Hosp Puerta Hierro, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1701
引用
收藏
页码：588A / 588A
页数：1
相关论文
共 50 条
  • [21] Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience
    Brillanti, S
    Miglioli, M
    Barbara, L
    JOURNAL OF HEPATOLOGY, 1995, 23 : 13 - 16
  • [22] Interferon successful in both prior non-responders and prior relapsers with hepatitis C
    不详
    AIDS PATIENT CARE AND STDS, 1999, 13 (02) : 132 - 132
  • [23] Retreatment of HCV relapsers and non-responders on interferon treatment
    Negi, T. S.
    Choudhuri, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A41 - A41
  • [24] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [25] Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant α-interferon
    Bresci, G
    Parisi, G
    Bertoni, M
    Scatena, F
    Capria, A
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 75 - 78
  • [26] Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
    Pessoa, Mario G.
    Cheinquer, Hugo
    Almeida, Paulo R. L.
    Silva, Giovanni F.
    Lima, Maria Patelli J. S.
    Parana, Raymundo
    Lacerda, Marco A.
    Parise, Edison R.
    Pernambuco, Jose R. B.
    Pedrosa, Suelene S.
    Teixeira, Rosangela
    Sette, Hoel, Jr.
    Tatsch, Fernando
    ANNALS OF HEPATOLOGY, 2012, 11 (01) : 52 - 61
  • [27] The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
    Abbasi, Fahimeh
    Bamdad, Taravat
    Ghadimi-Moghadam, Abdolkarim
    Chubin, Hamzeh
    Jamalidoust, Marzieh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (03)
  • [28] Amantadine-HCL treatment of chronic hepatitis C in non-responders to alpha-interferon.
    Parolin, MB
    Lacerda, MA
    Lopes, RW
    HEPATOLOGY, 1998, 28 (04) : 714A - 714A
  • [29] Proposal of combined therapy with ursodeoxycholate and glutathione for patients with chronic hepatitis C who are non-responders to interferon therapy.
    Ishii, K
    Nagai, TH
    Hata, S
    Kora, T
    Nagai, K
    Okajima, T
    Hatori, T
    Sumino, Y
    GASTROENTEROLOGY, 1996, 110 (04) : A1218 - A1218
  • [30] Predictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.
    Akarca, US
    Sayiner, A
    Ersoz, G
    Gunsar, F
    Ozacar, T
    Batur, Y
    HEPATOLOGY, 1999, 30 (04) : 631A - 631A
12345